Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc.: Vertex to Acquire Crinetics Pharmaceuticals

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
The Joplin Globe

Master Naturalists information meeting set for July 21

Missouri Master Naturalists, Chert Glades Chapter, will host an informational meeting for anyone interested in joining the fall Missouri Master Naturalists training class.

Artificial cell manages a few rounds of cell division

In this case, the gene encoding T7 RNA polymerase was added to the SpudCell genome, and it was made by those artificial cells ...
PharmTech

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.